What to expect from biotech in 2017: Pros

David Nelson, Belpointe asset management, and Luke Timmerman, Timmerman Report, forecast 2017 trends in biotech and if the space is something to consider for your portfolio.
03:20
Wed, Dec 28 20163:32 PM EST